Two North American entrepreneurs have put millions of dollars into exploring the treatment efficacy of psychedelics, based on personal experience of using them to help deal with their own mental health issues.
Toronto-based charity the Nikean Foundation has made a CAD $5m donation to research into the use of psychedelics at the Toronto University Health Network (UHN), while Journey Clinical of New York has raised USD $3m for research into psychedelic-assisted psychotherapy.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
